miRNAs as Circulating Biomarkers for Alzheimer’s Disease and Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|12|3|217-225

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.12, Iss.3, 2016-05, pp. : 217-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

6th International Conference on Alzheimer’s Disease and Parkinson’s Disease

By Lahiri Debomoy K  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1433-1440

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 22-45

Bentham Science Publishers

Access to resources Recommend Favorite

SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer’s and Parkinson’s disease

By O’Neill Michael J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1369-1373

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl   Henchcliffe Claire  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite